Trump strikes deal with Eli Lilly, Novo Nordisk to cut GLP-1 weight-loss drug prices
President Donald Trump announced a landmark agreement Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to dramatically slash prices for their blockbuster weight-loss drugs, potentially cutting monthly costs from over $1,300 to as low as $149. The deal marks a major victory for the administration’s “Most Favored Nation” pricing push and signals a turning […]
Read More